Oscar Health

CEO Mark Bertolini brings deep payer pedigree from Aetna and a clear operating cadence; CFO R. Scott Blackley has strong public company finance experience. The team is acting quickly with repricing, cost takeout, and product focus, and communicates targets and levers with specificity.

Governance and alignment are adequate, though founder ownership influence is lower than at founder-led compounders. Execution under the 2025 shock will be the true test.